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A B S T R A C T
Ethnopharmacological relevance: Marantodes pumilum (Blume) Kuntze has traditionally been used to firm the
uterus after delivery, however scientific evidences behind this claim is still lacking.
Aims of study: To demonstrate Marantodes pumilum leaves aqueous extract (MPE) has an effect on uterine
contraction after delivery and to elucidate the molecular mechanisms involved.
Methods: Day-1 post-delivery female rats were given MPE (100, 250 and 500mg/kg/day) orally for seven
consecutive days. A day after the last treatment (day-8), rats were sacrificed and uteri were harvested and
subjected for ex-vivo contraction study using organ bath followed by protein expression and distribution study by
Western blotting and immunohistochemistry techniques, respectively. The proteins of interest include calmo-
dulin-CaM, myosin light chain kinase-MLCK, sarcoplasmic reticulum Ca2+-ATPase (SERCA), G-protein α and β
(Gα and Gβ), inositol-triphosphate 3-kinase (IP3K), oxytocin receptor-OTR, prostaglandin (PGF)2α receptor-
PGFR, muscarinic receptor-MAChR and estrogen receptor (ER) isoforms α and β. Levels of estradiol and pro-
gesterone in serum were determined by enzyme-linked immunoassay (ELISA).
Results: Ex-vivo contraction study revealed the force of uterine contraction increased with increasing doses of
MPE. In addition, expression of CaM, MLCK, SERCA, Gα, Gβ, IP3K, OTR, PGF2α, MAChR, Erα and ERβ in the
uterus increased with increasing doses of MPE. Serum analysis indicate that estradiol levels decreased while
progesterone levels remained low at day-8 post-partum in rats receiving 250 and 500mg/kg/day MPE.
Conclusions: These findings support the claims that MPE help to firm the uterus and pave the way for its use as a
uterotonic agent after delivery.
1. Introduction
Marantodes pumilum (Blume) Kuntze (M. pumilum) is an indigenous
plant of Southeast Asia. Locally known as Kacip Fatimah in Malaysia
and Selusoh Fatimah in Indonesia (Giribabu et al., 2018b; Wan Hassan
Wan, 2007), M. pumilum has been used by many generations of
Southeast Asian women to induce and facilitate delivery and to firm the
uterus after delivery where the latter could help to reduce the risk of
post-partum haemorrhage (Manda et al., 2014). A study by Teoh et al.
(2013) has found that M. pumilum is one of the herb commonly used by
the Malaysian women during the post-partum period. Beside its re-
ported benefits on the female reproductive system, M. pumilum leaves
has been found to possess other health beneficial effects including anti-
tumour and anti-inflammatory (Karimi et al., 2013), promoting skin
collagen synthesis (Chua et al., 2012), protecting skin against photo-
ageing (Choi et al., 2010), preventing post-menopausal osteoporosis
(Effendy et al., 2017; Mohd Effendy et al., 2015) and promoting healing
of the osteoporotic fracture (Abd Jalil et al., 2012). In addition, other
parts of M. pumilum such as roots and stems have also been used as
medication, often in the form of decoction (Ibrahim and Jaafar, 2011).
Previously, our study has shown that the leaves of M. pumilum contain
high levels of phenolic acids, flavanoids and diterpenoid which might
contribute to its health beneficial effects (Tan et al., 2019).
Uterine contraction is essential for sperm and embryo transport to
and from the Fallopian tubes, respectively (Bulletti et al., 2000; Miller,
2018). In addition, uterine contraction also helps to shed the necrotic
endometrium during menstruation and to expulse the foetus and pla-
centa at delivery (Jabbour et al., 2006). In post-delivery period, con-
traction helps the uterus to involute (Braga Paiano et al., 2019). Uterine
contraction can be modulated by many factors such as hormones in-
cluding oxytocin, estrogen and progesterone (Salleh et al., 2015). Apart
from hormone, neurotransmitters such as acetylcholine could also sti-
mulate uterine contraction (Sadraei et al., 2012). Contraction is in-
itiated by binding of the hormone/neurotransmitter ligands on their
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respective receptors in the myometrium which are coupled to G-protein
α, β and γ (Phaneuf et al., 1993). Activation of G-proteins will lead to
production of second messenger including phospholipase C (PLC)
(Taylor et al., 1991). Activation of phospholipases will result in pro-
duction of diacylglycerol and IP3 which triggers Ca2+ released from the
sarcoplasmic reticulum (SR) and influx of Ca2+ from extracellular fluid
(Taylor et al., 1991). The IP3-mediated Ca2+ release from SR is the
major factor that is involve in the opening of the voltage-operated Ca2+
(VOC) channels trigger an action potential (AP) (Wrayzx et al., 2003).
Besides, increased global intracellular Ca2+ will lead to formation of
Ca2+-calmodulin complex which will cause activation of myosin light
chain kinase (MLCK) and phosphorylation of the regulatory myosin
light chains (Johnson et al., 1996) and subsequent cross-bridging be-
tween actin and myosin (Shojo and Kaneko, 2001). Following com-
pletion of contraction, relaxation is achieved partly via removing Ca2+
ions from the cytoplasm into the sarcoplasmic reticulum via SERCA
pumps (Noble et al., 2009). The role of SERCA in sequestering the Ca2+
into the sarcoplasmic reticulum has been investigated in pregnant rat
myometrium (Shmigol et al., 1999).
Although M. pumilum has been claimed to help firm the uterus after
delivery (Teoh et al., 2013), there were no scientific evidence to sup-
port this claim. Moreover, the underlying molecular mechanisms are
unknown. Therefore, this study was aimed to identify the effect of M.
Pumilum on uterine contraction post-delivery and to elucidate the mo-
lecular mechanisms involved. This study is important as it could justify
the use of this herb as a uterotonic agent for women in the post-delivery
period, which could help to reduce complication such as post-partum
haemorrhage.
2. Methods
2.1. Plant source and extraction
Fresh leaves of Marantodes pumilum (Blume) Kuntze var alata sp. was
obtained from Tapah district in Perak, Malaysia. The plant sample was
deposited at Herbarium in Rimba Ilmu, University of Malaya, Kuala
Lumpur for identification with assigned herbarium number: KLU49047.
The leaves were air-dried and then grounded into powder. Each 400 g
of powdered leaves was soaked in 2 L distilled water for 48 h. The
suspension was filtered and the filtrate was subjected to freeze-drying
which yielded 7.36% w/w, dry weight basis. The extract was stored at
−20 °C until use. The stock solution was prepared by dissolving small
aliquots of the extract in distilled water.
2.2. Animal preparation
Adult female Sprague-Dawley (SD) rats weighing 220–250 g were
purchased from local supplier and were housed under standard en-
vironmental condition with temperature between 25–30 °C, humidity
between 30-70%. Animals had free access to rodent food pellet and tap
water ad libitum. All experimental procedures were approved by
Institutional Animal Care and Use Committee, University of Malaya
with ethics number 2016–170714/PHYSIO/R/NS.
Female rats at pre-oestrous which was identified by daily vaginal
smear following to the method as previously described (Marcondes
et al., 2002), were allowed to mate at 1:1 ratio with adult male rat by
placing them together in a cage, overnight (Giribabu et al., 2014). The
presence of vaginal plug or sperm in the vaginal smear the next
morning indicates day 1 pregnancy. The female rats were allowed to
pregnant till delivery, usually 21 ± 2 days. The presence of pups was
designated as day 1 post-delivery (post-partum). The pups were hu-
manely sacrificed while the dams were given oral Marantodes pumilum
(Blume) Kuntze leaves extract (MPE) for seven (7) consecutive days. The
groupings were as follows:
Group 1: received distilled water only (C)
Group 2: received 100mg/kg/day MPE (MPE100)
Group 3: received 250mg/kg/day MPE (MPE250)
Group 4: received 500mg/kg/day MPE (MPE500)
MPE was orally administered by using 18G oral-gavage tube. MPE
doses were selected based on the previous reported effective dose and at
these doses, no adverse effects when observed either in humans or
animals (Abdul Kadir et al., 2012a, 2012b; Dianita et al., 2015; Ezumi
et al., 2007; Mohd Effendy and Shuid, 2014). Following completion of
oral MPE treatment (day 8), post-partum rats were humanely sacrificed
by cervical dislocation and uteri were removed and subjected for ex-vivo
uterine contraction study. Following completion of the study, uteri
were subjected for protein expression and distribution analyses.
2.3. Ex-vivo uterine contraction study
Ex-vivo uterine contraction study was performed following the
method as previously described Salleh et al. (2015).The mid portion of
uterine horn was used. In brief, uteri were mounted vertically in an
organ bath pre-filled with Krebs-HEPES buffer solution that contains
the following compositions: 154.0mM NaCl, 5.4mM KCl, 2.0 mM
MgSO4, 2.0 mM CaCl2, 8.0 mM D-glucose and 10.0mM HEPES (Sukwan
et al., 2014). The pH of the solution was adjusted to 7.40, and tem-
perature was maintained at 37 °C. The solution was continuously aer-
ated with 95% O2/5% CO2. Each strip of uterine horns was hang under
1 g resting tension and the force was allowed to equilibrate for 30min.
Buffer solution was replaced every 15min by flushing and refilling
techniques. Contractile forces were recorded isometrically by using a
force transducer connected to a bridge amplifier and then to a Pow-
erLab data acquisition system (ADI Instrument, Australia). After a
stable spontaneous contraction was achieved, 1×10−2M acetylcho-
line (Ach) was added to generate maximum contraction force. The
contractile waves were recorded. At the end of the experiment, uteri
were patted dry and their wet weight was determined. The force of
uterine contraction was taken as the ratio of contraction amplitude to
its wet weight (tension/g).
Abbreviations
Ach Acetylcholine
BSA Bovine serum antigen
CaCl2 Calcium chloride
CAM Cell adhesion molecules
DAB Diaminobenzidine
ERα Estrogen receptor alpha
ERβ Estrogen receptor beta
FSH Follicle stimulating hormone
Gα G protein α
Gβ G protein β
HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid)
KCl Potassium chloride
MAChR Muscarinic acetylcholine receptor
MgSO4 Magnesium sulfate
MLCK Myosin light chain kinase
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2.4. Measurement of serum hormone levels
1–2ml of venous blood was collected from rats’ tail vein on day 1 of
post-partum and prior to sacrificed and was allowed to clot at 4 °C, then
centrifuged at 3000 rpm at 4 °C for 15min. The serum was carefully
pipetted and stored at −80 °C and then sent to the division of labora-
tory medicine, University Malaya Medical Centre for hormone profiles
analyses including analysis of estradiol and progesterone by using en-
zyme-linked immunosorbent assay (ELISA) technique.
2.5. Protein distribution analyses by immunohistochemistry
Once harvested, uteri were fixed immediately in 10% formalin
overnight. Prior to processing, uteri were dehydrated through in-
creasing concentrations of ethanol, cleared in xylene and blocked in
paraffin wax as previously described (Giribabu et al., 2017). Tissues
were then cut into 5 μm sections, deparaffinised in xylene and finally
rehydrated in reducing concentrations of ethanol. 10% HistoVT buffer
(Nacaai Teque, Japan) was used to retrieve the antigen. For im-
munohistochemistry, tissue sections were incubated with 3% H2O2,
then blocked in 5% bovine serum antigen (BSA) for 1 h at room tem-
perature. This was followed by incubation in primary antibodies: rabbit
polyclonal calmodulin (CaM), estrogen receptor α (Erα) and estrogen
receptor β (ERβ) (Santa Cruz: sc-5537, sc-7207, sc-8974, respectively)
and goat polyclonal myosine light chain kinase (MLCK), SERCA, oxy-
tocin receptor (OTR), prostaglandin-2αreceptor (PGF2αR) and mus-
carinic receptor (M2) (Santa Cruz: sc-12450, sc-8094, sc-8102, sc-
33303, sc-7472, respectively). Primary antibody incubation was done
in PBS containing 1% BSA and tween-20 overnight. A day after in-
cubations, sections were rinsed thrice, 5 min each in PBS, then in-
cubated with IgG-HRP conjugated secondary antibody for 1 h at room
temperature. The proteins were stained dark-brown by immersing in
diaminobenzidine (DAB) (Nacalai Tesque, Japan). Sections were then
rinsed for 5min with deionized water. Hematoxylin was used to
counterstain and visualize the nuclei. The slides were dehydrated
through increasing concentrations of ethanol and xylene and were
covered with a drop of DPX mounting medium. All histological images
were viewed under Nikon Eclipse 80i camera attached to a light mi-
croscope.
2.6. Protein quantification by Western blotting
Immediately following harvesting, uteri were snap frozen in liquid
nitrogen and were then stored at −80 °C. Protein extraction was done
by using a PRO-PREP™ solution (Intron, Korea) as previously described
(Giribabu et al., 2018a). In brief, 50 μg proteins were mixed with a
loading dye, separated in SDS-PAGE and transferred onto a PVDF
membrane (BIORAD, USA). The membranes were then blocked with 5%
Fig. 1. Effect of MPE on uterine contraction ex-vivo. A) A powerlab tracing showing uterine contractile force B) Bar chart showing mean force of uterine
contraction with different doses of MPE. Data were expressed as mean ± SEM from six independent observations. *p < 0.05 compared to control (without MPE).
Table 1
Serum sex-steroid levels and estrogen/progesterone ratio in post-partum rats receiving MPE.
C MPE100 MPE250 MPE500
Estradiol
Day 1 139.9 ± 7.48 150.7 ± 5.39 142.75 ± 4.86 152.5 ± 7.94
Day 8 170.4 ± 8.73* 203.78 ± 9.21* 128.21 ± 11.85 135.66 ± 15.45
Progesterone
Day 1 18.87 ± 4.56 17.73 ± 3.19 18.05 ± 6.91 19.71 ± 3.88
Day 8 125.12 ± 6.55* 62.44 ± 5.82* 16.83 ± 5.52 18.39 ± 6.16
Estrogen/Progesterone ratio (Day 8) 1.36 3.25 7.61 7.37
Data were expressed as mean ± SEM from six independent observations. *p < 0.05 when compared to Day 1.
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BSA for 60min at room temperature and were separately exposed to
primary antibodies (as above) with addition of primary antibodies
against G-protein α (sc-25413), G-protein β (sc-378) and IP3K (sc-
39064) in PBS containing 1% BSA and tween-20 overnight. Antibodies
against β-Actin (sc-69879), GAPDH (sc-25778) and vinculin (H-300)
(sc-5573) were used as loading controls, at concentration of 0.1 μg/ml
(1: 1000). The blots were rinsed thrice in PBS-Tween (PBS-T), for 5min
each. The membranes were then incubated with anti-rabbit and anti-
goat HRP conjugated secondary antibodies (Santa Cruz, CA, USA) at a
concentration of 0.2 μg/ml (1:2000), for 1 h and protein bands were
detected by using DAB peroxidase staining (DAB kit, Nacalai Tesque).
Band images were captured by using UVP BioSpectrum Imaging System
(UVP, Canada), and density of each band was quantified by using Image
J software (NIH version 1.49j; National Institutes of Health, Bethesda,
MD, USA). The ratio of each target protein/loading control was de-
termined and was considered as the expression levels of the targets.
2.7. Statistical analysis
Results (n=6) were expressed as mean ± SEM. Statistical sig-
nificance was evaluated by one-way analysis of variance (ANOVA) and
individual comparison was obtained by using Tukey post-hoc test.
p < 0.05 was considered as significant.
3. Results
3.1. Effect of MPE on serum sex-steroid levels and estrogen/progesterone
ratio
Serum estradiol levels significantly increased in control group and
in group that received MPE100 at day 8 postpartum when compared to
day 1 (Table 1). However, in group that received MPE250 and MPE500,
no changes in serum estradiol level was observed. In the meantime,
there were marked rise in serum progesterone levels in control group
and a moderate rise in the group that received MPE100 at day 8 post-
partum when compared to day 1 (p < 0.05). On the other hand, in the
groups that received MPE250 and MPE500, no significant rise in serum
progesterone levels were observed. Estrogen/Progesterone ratio were
found to be highly elevated in MPE250 and MPE500 groups, approxi-
mately 5.5 and 2.3 folds when compared to MPE100 and control
groups, respectively.
3.2. Effects of MPE on uterine contractile force
The ratio of uterine contractile force to uterine wet weight was
approximately 1.48 fold higher in post-partum rats treated with 250
and 500mg/kg/day MPE when compared to control (p < 0.05)
Fig. 2. Representative Western blot images and band intensity analysis of (A) CaM (C) MLCK (E) SERCA and immunohistochemistry images showing (B)
CaM (D) MLCK (F) SERCA distribution in the uterus of post-partum rats. C= control, MPE100=100mg/kg/day, MPE250=250mg/kg/day,
MPE500=500mg/kg/day of MPE. (n=6). Images were captured at 20x magnification. Scale bar indicates 100 μm.
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(Fig. 1). In the meantime, no significant increase in uterine contractile
force was observed following treatment with MPE100 when compared
to the control.
3.3. Effects of MPE on expression and distribution of contractile proteins
(CaM, MLCK and SERCA) in the uterus
3.3.1. Expression and distribution of CaM
Expression of CaM increased with increasing doses of MPE. The
highest CaM expression was observed in the uterus of MPE500 treated
rats (Fig. 2A). In parallel, a relatively higher CaM protein distribution
was observed in the uterus in particular in the circular and longitudinal
smooth muscles in groups that received 500mg/kg/day MPE treatment
(Fig. 2B).
3.3.2. Expression and distribution of MLCK
Expression of MLCK increased with increasing doses of MPE, being
highest in group that received MPE500 treatment (Fig. 2C). In parallel,
a relatively higher MLCK protein distribution could be seen in the
myometrium of MPE500 treated rats as compared to rats that received
other treatments (Fig. 2D).
3.3.3. Expression and distribution of SERCA
Expression of SERCA in the uterus increased dose-dependently fol-
lowing MPE-treatment, the highest being in MPE500-treated rats
(Fig. 2E). In parallel, distribution of SERCA was observed to be rela-
tively higher in the myometrium of MPE500-treated rats when com-
pared to the rats that received MPE100 and MPE250 treatment as well
as the control rats (Fig. 2F).
3.4. Effect of MPE on expression of intracellular signalling proteins in the
uterus
Expression of Gα protein was significantly increased in the uterus of
postpartum rats receiving MPE250 and MPE500 treatment (p < 0.05
when compared to control) (Fig. 3). There was an approximately 4-fold
increase in expression of Gβ protein in the uterus following MPE
treatment when compared to control (Fig. 3). In the meantime, ex-
pression of IP3K protein in the uterus was also increased following
treatment with MPE (Fig. 3).
3.5. Effect of MPE on expression and distribution of uterotonin receptors
(OTR, PGF2R ad MAChR) in the uterus
3.5.1. Expression and distribution of OTR
There was an increased in OTR expression in the uterus following
MPE treatment, the highest being in the group that received MPE500
(Fig. 4A). In parallel, a relatively higher OTR distribution was observed
in the myometrium in the group that received 500mg MPE (Fig. 4B).
3.5.2. Expression and distribution of MAChR
There was a dose-dependent increase in MAChR expression in the
uterus following MPE treatment, the highest being in MPE500 treated
group (Fig. 4C). In parallel, a relatively higher MAChR distribution was
observed in the myometrium following MPE500 treatment when com-
pared to other groups (Fig. 4D).
3.5.3. Expression and distribution of PGF2αR
PGF2αR expression was highest in the uterus following MPE500
treatment (Fig. 4E). In parallel, a relatively higher PGF2αR distribution
was observed in the myometrium following MPE500 treatment when
compared to other groups (Fig. 4F).
3.6. Effects of MPE on estrogen receptors (ERα and ERβ) in the uterus
3.6.1. Expression and distribution of ERα
Expression of ERα was highest in the uterus following MPE250 and
MPE500 treatments (Fig. 5A). In parallel, a relatively higher ERα dis-
tribution was observed in the myometrium following MPE250 and
MPE500 treatment when compared to other groups (Fig. 5B).
3.6.2. Expression and distribution of ERβ
Expression of ERβ was highest in the uterus following MPE500
treatment (Fig. 5C). In parallel, a relatively higher ERβ distribution was
observed in the myometrium following MPE250 and MPE500 treat-
ments as compared to other groups, consistent with the protein ex-
pression findings (Fig. 5D).
4. Discussion
To the best of our knowledge, this study is the first to provide evi-
dences supporting the claims that M. pumilum helps in inducing uterine
contraction in the post-delivery period. Consequently, this effect could
help the uterus to adequately firm and assists in reducing the risk of
post-partum haemorrhage which is a common complication after de-
livery (Gallos et al., 2019). We have shown that oral administration of
MPE in rats particularly at high dose of 500mg/kg/day was able to
enhance uterine contraction which imply that MPE has potential to be
used as an agent alternative to conventional drug like oxytocin in order
to firm the uterus after delivery (Anderson and Etches, 2007).
Apart from the functional findings, our study has unravelled the
mechanistic action underlying the uterotonic effect of MPE. There were
up-regulation of uterotonin receptors and other contractile-related
proteins in the uterus such as CaM and MLCK following MPE treatment.
In addition, intracellular signalling proteins i.e. G-protein α and β and
IP3K were also found to be upregulated by MPE treatment.
Additionally, expression of Ca2+ transport protein such as SERCA, ER
isoforms α and β in the uterus were enhanced by MPE treatment. There
were several implications for the increased levels of ER in the uterus.
Higher ER levels would augment the effect of estrogen on this organ.
Studies have shown that ER could act as a transcription factor to induce
gene transcription including genes that encodes the receptors for
Fig. 3. Representative Western blots images and band intensity analysis of
Gα, Gβ and IP3K in the uterus of post-partum rats. *p < 0.05 as compared
to C. C = control, MPE100 = 100 mg/kg/day, MPE250 = 250 mg/kg/day,
MPE500 = 500 mg/kg/day of MPE, (n=6).
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uterotonins (Kuiper et al., 1997; Shughrue et al., 1998). Furthermore,
distribution of ERα and ERβ were localized to the uterine smooth
muscle cells which indicate that the target of MPE was the myome-
trium. It was reported that in the uterus, ERα is the predominant sub-
type (Pelletier and El-Alfy, 2000). Activation of ER by estrogen would
result in up-regulation of uterotonin receptors such as oxytocin, pros-
taglandin and muscarinic receptors (Gruber and O'Brien, 2011). These
receptor levels were found to be markedly increased in the uterus at
around the time of delivery under the influence of estrogen (Miyado
et al., 2015; Wu et al., 2000). Increased responsiveness of myometrium
to estrogen in the post-delivery period is important as falling estrogen
levels could cause decreased in the force of uterine contraction (Kota
et al., 2013). Estrogen has also been reported to increase oxytocin
-related pathway and enhances uterine contractility in rats (An et al.,
2013).
Increased number of uterotonin receptors as observed following
MPE treatment in the postpartum period would augment the effect of
oxytocin, prostaglandins and acetylcholine on the uterus, which sub-
sequently increases the uterine contractile forces. Maintaining high
levels of OTR in the myometrium in the post-delivery period is im-
portant since OTR levels which increases approximately 200 times at
end of gestation secondary to the rise in estrogen, will fall sharply by
more than seven folds in the first 24 h after delivery which would
reduce uterine contractility (Gimpl and Fahrenholz, 2001). Since oral
MPE treatment up-regulates expression of OTR, therefore there is a
likelihood that uterine contraction force would be maintained. In ad-
dition to OTR, MAChR levels also increased following MPE treatment in
the post-partum period which could help to amplify the ACh action
resulting in enhanced force of uterine contraction. It has been reported
that expression of MAChR in the uterus greatly increased during par-
turition which then fell sharply following delivery (). Therefore,
maintaining high levels of uterine MAChR could help to sustain uterine
contraction in the post-delivery period. Additionally, high expression of
PGF2αR in the myometrium following oral MPE treatment in the post-
delivery period would also help to increase the force of uterine con-
traction in view that prostaglandins has been shown to play an im-
portant role in enhancing contraction of the myometrium during labor
and in the post-partum period (O'Brien, 1995).
This study has revealed that expression of CaM and MLCK in the
post-partum uterus increased following oral MPE treatment where these
would directly cause increased in the force of uterine contraction. The
upregulation of CaM would enhance formation of Ca2+-calmodulin
complex which then activate the MLCK enzymes leading to phosphor-
ylation of myosin light chain, which ultimately enhances the formation
of actin-myosin cross-bridges (Hill-Eubanks et al., 2011). Meanwhile,
the elevated levels of SERCA in the myometrium following MPE
Fig. 4. Western blot image and band intensity analysis of (A) OTR (C) MAChR (E) PGF2αR and immunohistochemistry images showing (B) OTR (D) MAChR
(F) PGF2αR distribution in the myometrium of post-partum rats. C= control, MPE100=100mg/kg/day, MPE250=250mg/kg/day, MPE500=500mg/kg/
day of MPE. (n=6). Images were captured at 20x magnification. Scale bar indicates 100 μm.
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treatment in post-partum uterus would assist uterine relaxation via re-
uptake of cytoplasmic Ca2+ into the SR (Berridge, 2008). Increased in
IP3K in the uterus following MPE treatment would increase the influx of
Ca2+ into the cytoplasm following the binding of IP3K to its specific
receptor on the SR. The IP3-mediated Ca2+ release from SR is the major
factor that lead to opening of voltage-operated Ca2+ (VOC) channels in
the myometrium, leading to the influx of extracellular Ca2+ (Wrayzx
et al., 2003). In the meantime, increased levels of G proteins α and β in
the uterus would turn on a cascade of events starting with membrane
phospholipase C (PLC) stimulation till production of IP3 which func-
tions are described above. G-proteins activation would also inhibit
myosin light chain phosphatase (MLCP) enzyme which is involve in
decreasing the force of uterine contraction and induces uterine smooth
muscle relaxation (Noda et al., 1995).
The observed uterotonic action of MPE could be attributed to the
presence of bioactive compounds in the extract. We recently published
a LCMS/MS data analysis which showed that the same extract contains
decarboxylated gallic acid (pyrogallol), gallic acid, protocatechuic acid,
4-hydroxybenzoic acid, vanillic acid, myricetin, kaempferol-3-O-ruti-
noside, kaempferol-7-O-glucoside, 3-3-Di-O-methyellagic acid, api-
genin and phytol (Tan et al., 2019). Pyrogallol has been reported to
affect prostaglandin synthesis in the rat and human uterus (Kelly and
Abel, 1981). 4-hydroxybenzoic acid has been found to possess estrogen-
like activity on the uterus however its main action in this organ has not
been defined (Koda et al., 2005). Apigenin and myricetin have been
reported to possess estrogenic effect on the uterus in inmmature mice
(Barlas et al., 2014). In the meantime, estrogenic activity of kaemferol
has been widely reported (Breinholt et al., 2000; Stroheker et al., 2002).
It is plausible that these compounds might induce up-regulation of the
uterine contractile mechanisms (as above) via binding to ER that were
Fig. 5. Western blot image and band intensity
analysis of (A) ERα (C) ERβ and im-
munohistochemistry images showing (B) ERα
(D) ERβ distribution in the uterus of post-
partum rats. C= control, MPE100=100mg/kg/
day, MPE250=250mg/kg/day, MPE500=
500mg/kg/day of MPE. (n=6). Images were cap-
tured at 20x magnification. Scale bar indicates
100 μm.
Fig. 6. Summary of the molecular mechanisms
involved underlying the effect of MPE on uterine
contraction. MPE bind to ER isoforms in the cyto-
plasm forming a ligand-receptor complex that
translocate into the nucleus leading to transcription
of genes that encodes protein including OTR, PGFR,
MAChR, CaM, MLCK and SERCA. MPE might also
increase G-proteins (Gα and Gβ) and IP3K levels in
the myometrium. The resulting increase in IP3K
would cause increase in Ca2+ intracellularly via
increasing influx of Ca2+ from the sarcoplasmic
reticulum (SR) or from extracellular fluid. Increased
sarcoplasmic Ca2+ levels would bind to CaM
forming Ca2+-CaM complex that activates the
MLCK. This would result in phosphorylation of
myosin light chain and ultimately cross-bridges be-
tween myosin and actin. Contraction is terminated
via re-uptake of intracellular Ca2+ into the SR in-
volving SERCA.
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abundantly presence in the uterus, resulting in a stronger force of
uterine contraction.
Meanwhile, serum sex-steroid hormone profiles in the post-partum
rats were also found to be altered following MPE treatment. The in-
creased in serum estradiol levels at day-8 post-partum in control rats
and in rats receiving 100mg/kg/day MPE might be due to the re-
commencement of the oestrous cycle as there was a report that in rats,
ovulation occur as early as 3 h after parturition (Connor and Davis,
1980). In the meantime, serum progesterone levels in control rats and
in rats receiving 100mg/kg/day MPE were also found to increase sig-
nificantly at day-8 post-partum, most probably due to the formation of
corpus luteum. On the other hand, serum estradiol levels at day-8
postpartum in rats that received MPE250 and MPE500 have no effect on
estradiol biosynthesis in the ovary. High dose MPE of 250 and 500mg/
kg/day however might suppress progesterone biosynthesis resulting in
no rise in serum progesterone levels in these rats at day-8 postpartum.
The detail mechanisms involved underlying MPE effect on progesterone
levels need to be identified. Suppression of progesterone levels in par-
ticular is important since progesterone is known to inhibit myometrial
contraction and consequently, this could help to alleviate the uterus
from its quiescent state (Soloff et al., 2011). Additionally, we found that
there were more than two-fold increase in estrogen/progesterone ratio
following MPE250 and MPE500 treatment, which indicate that the
uterus was highly contractile. Increased estrogen/progesterone ratio
has been found to be parallel with increased contractility of the uterus
(Trujillo et al., 2001). Our findings were consistent with the findings in
pre and post-menopausal women who were given 200mg/day M pu-
milum extract orally for 12 weeks where there were no significant
changes in estradiol levels (George et al., 2014). Similarly, no changes
in serum estradiol levels was observed in post-menopausal women
consuming 280mg/day M. pumilum for 6 months period (Abdul Kadir
et al., 2012a, 2012b). Despite of these, the effect of oral M. pumilum
treatment on serum progesterone levels in humans remain to be iden-
tified.
This study has several limitations. The functional study was pre-
liminary, thus further works such as introducing inhibitors targeting at
the proteins of interest are needed in order to support the molecular
biological analysis. Inhibitors to uterotonin receptors such as atropine
(MAChR blocker) (Lochner and Thompson, 2016), atosiban (oxytocin
receptor blocker) (Abdullahi et al., 2018) and piprant (PG receptor
antagonist) (Kirkby Shaw et al., 2016) could be used to confirm the
involvement of these uterotonins in inducing myometrial contraction.
In the meantime, thapsigargin, a specific inhibitor for SERCA (Kumar
et al., 2019), DY-9836, a specific inhibitor for calmodulin (Wang et al.,
2017) and ML-7 and ML-9 (specific MLCK inhibitors) could be used to
confirm the involvement of these proteins in regulating myometrial
contraction during the post-partum period. Xestospongin B, a compe-
titive inhibitor of IP3K-mediated Ca2+ signalling could be used to
confirm the involvement of IP3K in MPE-mediated effect in the uterus
in the period post-partum (Jaimovich et al., 2005).
In conclusion, there were several mechanisms which could possibly
be involve in MPE-mediated uterine contraction which include up-
regulation of intracellular proteins that participate in the uterine
smooth muscle contraction. In addition, maintaining low progesterone
levels could abrogate uterine quiescence thus could increase the in-
tensity of uterine contraction (Astle et al., 2003). Other factors that
might also contribute towards increased uterine contraction include
increased expression of ER in the myometrium, where these could en-
hance the estrogen action on the uterus, in particular in causing upre-
gulation of the contraction-associated proteins. Fig. 6 summarizes the
possible mechanisms underlying MPE effect in inducing uterine con-
traction. Based on the above findings, M. pumilum var alata has po-
tential to be used as uterotonic herbal agent to enhance contraction of
the uterus after delivery.
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